secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001213900-24-076728
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics files 1-for-30 reverse stock split, reduces authorized shares to 250M
--------------------------------------------------------------------------------

- Stockholders approved 1-for-30 reverse split at Sept 3 annual meeting; effective Sept 11, 2024.
- Authorized common shares reduced from 750M to 250M via Sixth Certificate of Amendment.
- Board also amended 2021 Equity Plan to increase shares reserved from ~2.2M to ~10.6M (pre-split).
- Directors Gerald W. McLaughlin and Laura E. Benjamin re-elected to Class II.
- Trading symbol ALLR unchanged; no fractional shares, rounding up.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024076728/0001213900-24-076728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024076728/ea0213202-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-076728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer